| MeSH term | MeSH ID | Detail |
|---|---|---|
| Hemolysis | D006461 | 131 associated lipids |
| Uremia | D014511 | 33 associated lipids |
| Colitis, Ulcerative | D003093 | 24 associated lipids |
| Stomach Ulcer | D013276 | 75 associated lipids |
| Kidney Failure, Chronic | D007676 | 51 associated lipids |
| Nocardia Infections | D009617 | 6 associated lipids |
| Diarrhea | D003967 | 32 associated lipids |
| Diabetes Mellitus | D003920 | 90 associated lipids |
| Graft Occlusion, Vascular | D006083 | 11 associated lipids |
| Hypercalcemia | D006934 | 13 associated lipids |
| Neovascularization, Pathologic | D009389 | 39 associated lipids |
| Adenocarcinoma | D000230 | 166 associated lipids |
| Dermatitis, Contact | D003877 | 59 associated lipids |
| Bacterial Infections | D001424 | 21 associated lipids |
| Pain | D010146 | 64 associated lipids |
| Autoimmune Diseases | D001327 | 27 associated lipids |
| Lupus Erythematosus, Systemic | D008180 | 43 associated lipids |
| Genital Diseases, Female | D005831 | 7 associated lipids |
| Mouth Diseases | D009059 | 5 associated lipids |
| Meningococcal Infections | D008589 | 3 associated lipids |
tacrolimus
Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.
Cross Reference
Introduction
To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with tacrolimus?
tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Antimicrob. Agents Chemother. (2)
- Am. J. Physiol. Renal Physiol. (1)
- Drug Metab. Dispos. (1)
- Others (1)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with tacrolimus
PubChem Associated disorders and diseases
What pathways are associated with tacrolimus
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with tacrolimus?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with tacrolimus?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with tacrolimus?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with tacrolimus?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with tacrolimus?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with tacrolimus
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Fujii H et al. | Nonlinear decoding and asymmetric representation of neuronal input information by CaMKIIα and calcineurin. | 2013 | Cell Rep | pmid:23602566 |
| Matsa E et al. | Transcriptome Profiling of Patient-Specific Human iPSC-Cardiomyocytes Predicts Individual Drug Safety and Efficacy Responses In Vitro. | 2016 | Cell Stem Cell | pmid:27545504 |
| Sun B et al. | Imbalance between GABAergic and Glutamatergic Transmission Impairs Adult Neurogenesis in an Animal Model of Alzheimer's Disease. | 2009 | Cell Stem Cell | pmid:19951690 |
| Mohri T et al. | Rapid adhesion and spread of non-adherent colon cancer Colo201 cells induced by the protein kinase inhibitors, K252a and KT5720 and suppression of the adhesion by the immunosuppressants FK506 and cyclosporin A. | 1998 | Cell Struct. Funct. | pmid:9872566 |
| Kano Y et al. | Immunosuppressant FK506 induces sustained activation of MAP kinase and promotes neurite outgrowth in PC12 mutant cells incapable of differentiating. | 2002 | Cell Struct. Funct. | pmid:12502894 |
| Papaccio G et al. | The immunosuppressant FK506 inhibits the damage to mouse pancreatic islets induced by low dose streptozocin. | 1994 | Cell Tissue Res. | pmid:7525068 |
| Kotobuki N et al. | In vivo survival and osteogenic differentiation of allogeneic rat bone marrow mesenchymal stem cells (MSCs). | 2008 | Cell Transplant | pmid:18819258 |
| Johnson JD et al. | Different effects of FK506, rapamycin, and mycophenolate mofetil on glucose-stimulated insulin release and apoptosis in human islets. | 2009 | Cell Transplant | pmid:19500470 |
| Yook S et al. | Molecularly engineered islet cell clusters for diabetes mellitus treatment. | 2012 | Cell Transplant | pmid:22613624 |
| Almawi WY et al. | Inhibition of cytokine production and cytokine-stimulated T-cell activation by FK506 (tacrolimus)1. | 2001 | Cell Transplant | pmid:11714196 |
| Sugiyama K et al. | Comparative study of the cellular pharmacodynamics of tacrolimus in renal transplant recipients treated with and without basiliximab. | 2012 | Cell Transplant | pmid:22793066 |
| Ponte GM et al. | Resolution of severe atopic dermatitis after tacrolimus withdrawal. | 2007 | Cell Transplant | pmid:17436852 |
| Ding L et al. | Clinical Immunosuppressants Inhibit Inflammatory, Proliferative, and Reprogramming Potential, But Not Angiogenesis of Human Pancreatic Duct Cells. | 2015 | Cell Transplant | pmid:25198311 |
| Orr C et al. | Quantifying Insulin Therapy Requirements to Preserve Islet Graft Function Following Islet Transplantation. | 2016 | Cell Transplant | pmid:25853639 |
| Mijiti A et al. | Increased sensitivities of peripheral blood mononuclear cells to immunosuppressive drugs in cirrhosis patients awaiting liver transplantation. | 2006 | Cell Transplant | pmid:17299993 |
| Guérette B et al. | Control of inflammatory damage by anti-LFA-1: increase success of myoblast transplantation. | 1997 Mar-Apr | Cell Transplant | pmid:9142441 |
| Hara K et al. | Implantation of xenogeneic transgenic neural plate tissues into parkinsonian rat brain. | 1997 Sep-Oct | Cell Transplant | pmid:9331504 |
| Del Castillo JM et al. | Antiapoptotic effect of tacrolimus on cytokine-challenged human islets. | 2009 | Cell Transplant | pmid:19660176 |
| Tian C et al. | Differentiation of murine embryonic stem cells in skeletal muscles of mice. | 2008 | Cell Transplant | pmid:18522235 |
| Hefferan MP et al. | Optimization of immunosuppressive therapy for spinal grafting of human spinal stem cells in a rat model of ALS. | 2011 | Cell Transplant | pmid:21669047 |
| Odorico JS et al. | Improved solitary pancreas transplant graft survival in the modern immunosuppressive era. | 2000 Nov-Dec | Cell Transplant | pmid:11202579 |
| Froud T et al. | Resolution of neurotoxicity and beta-cell toxicity in an islet transplant recipient following substitution of tacrolimus with MMF. | 2006 | Cell Transplant | pmid:17176613 |
| Kokudo N et al. | Allogeneic hepatocyte and fetal liver transplantation and xenogeneic hepatocyte transplantation for Nagase's analbuminemic rats. | 1996 Sep-Oct | Cell Transplant | pmid:8889223 |
| Furukawa M et al. | Analysis of PCR microchimerism induced by intrathymic inoculation of donor alloantigens in rats. | 1996 Sep-Oct | Cell Transplant | pmid:8889237 |
| Tashiro H et al. | Monitoring for engraftment following rat orthotopic liver transplantation by in vitro amplification of Y-chromosome gene using polymerase chain reaction. | 1995 | Cell Transplant | pmid:7540919 |
| Han D et al. | Choice of immunosuppression influences cytomegalovirus DNAemia in cynomolgus monkey (Macaca fascicularis) islet allograft recipients. | 2010 | Cell Transplant | pmid:20587138 |
| Perry SS et al. | Direct effects of cyclosporin A on proliferation of hematopoietic stem and progenitor cells. | 1999 Jul-Aug | Cell Transplant | pmid:10478713 |
| Serrano T et al. | The effects of immunosuppressive agents on the function of human hepatocytes in vitro. | 2006 | Cell Transplant | pmid:17269448 |
| Markus PM et al. | Allogeneic hepatocyte transplantation using FK 506. | 1997 Jan-Feb | Cell Transplant | pmid:9040958 |
| Alemdar AY et al. | Liposomal formulations of tacrolimus and rapamycin increase graft survival and fiber outgrowth of dopaminergic grafts. | 2004 | Cell Transplant | pmid:15191164 |
| Kihara Y et al. | Comparative study of the cellular pharmacodynamics of calcineurin inhibitors between patients with chronic renal failure awaiting renal transplantation and cirrhosis patients awaiting liver transplantation. | 2009 | Cell Transplant | pmid:19775526 |
| Mijiti A et al. | Clinical significance of the cellular pharmacodynamics of tacrolimus in living-donor liver transplantation. | 2009 | Cell Transplant | pmid:19775528 |
| Akita K et al. | Effect of FK506 and anti-CD4 therapy on fetal pig pancreas xenografts and host lymphoid cells in nod/Lt, CBA, and BALB/c mice. | 1994 Jan-Feb | Cell Transplant | pmid:7512875 |
| Yasunami Y et al. | Donor-specific unresponsiveness induced by intraportal grafting and FK506 in rat islet allografts: importance of low temperature culture and transplant site on induction and maintenance. | 1994 Jan-Feb | Cell Transplant | pmid:7512876 |
| Yasunami Y and Ikeda S | Induction of donor specific unresponsiveness in rat islet allografts by intraportal grafting and FK506. | 1994 | Cell Transplant | pmid:7512877 |
| Kumar S et al. | A cytokine promoter/yellow fluorescent protein reporter transgene serves as an early activation marker of lymphocyte subsets. | 2005 | Cell. Immunol. | pmid:16405934 |
| Genestier L et al. | Cyclosporin A and FK506 inhibit activation-induced cell death in the murine WEHI-231 B cell line. | 1994 | Cell. Immunol. | pmid:7514101 |
| Aagaard-Tillery KM and Jelinek DF | Inhibition of human B lymphocyte cell cycle progression and differentiation by rapamycin. | 1994 | Cell. Immunol. | pmid:7517796 |
| Keicho N et al. | Effects of an immunosuppressant, FK506, on interleukin 1 alpha production by human macrophages and a macrophage-like cell line, U937. | 1991 | Cell. Immunol. | pmid:1703047 |
| Soldevila G et al. | Analysis of the individual role of the TCRzeta chain in transgenic mice after conditional activation with chemical inducers of dimerization. | 2001 | Cell. Immunol. | pmid:12088411 |
| Metcalfe S et al. | FK506 and cyclosporin A each inhibit antigen-specific signaling in the T cell line 171 in the absence of a calcium signal. | 1994 | Cell. Immunol. | pmid:7522130 |
| Staruch MJ et al. | Distinctive calcineurin-dependent (FK506-sensitive) mechanisms regulate the production of the CC chemokines macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, and RANTES vs IL-2 and TNF-alpha by activated human T cells. | 1998 | Cell. Immunol. | pmid:9878113 |
| Dumont FJ et al. | Dominant mutations confer resistance to the immunosuppressant, rapamycin, in variants of a T cell lymphoma. | 1995 | Cell. Immunol. | pmid:7538911 |
| Prud'homme GJ et al. | Effects of cyclosporin A, rapamycin, and FK520 on peripheral T-cell deletion and anergy. | 1995 | Cell. Immunol. | pmid:7543371 |
| Lin CS et al. | FK-506 and cyclosporin A inhibit highly similar signal transduction pathways in human T lymphocytes. | 1991 | Cell. Immunol. | pmid:1707760 |
| Adachi S and Iwata M | Duration of calcineurin and Erk signals regulates CD4/CD8 lineage commitment of thymocytes. | 2002 | Cell. Immunol. | pmid:12142035 |
| Haasch D et al. | T cell activation induces a noncoding RNA transcript sensitive to inhibition by immunosuppressant drugs and encoded by the proto-oncogene, BIC. | 2002 May-Jun | Cell. Immunol. | pmid:12426003 |
| Pores-Fernando AT et al. | Calcineurin-dependent lytic granule exocytosis in NK-92 natural killer cells. | 2009 | Cell. Immunol. | pmid:18762287 |
| Kay JE et al. | The mechanism of action of the immunosuppressive drug FK-506. | 1989 | Cell. Immunol. | pmid:2478301 |
| Hidaka M et al. | Involvement of intestinal intraepithelial lymphocytes in turnover of intestinal epithelial cells: morphological and functional alterations due to daily administration of FK506. | 2012 | Cell. Immunol. | pmid:23228594 |
| Hattori Y and Nakanishi N | Effects of cyclosporin A and FK506 on nitric oxide and tetrahydrobiopterin synthesis in bacterial lipopolysaccharide-treated J774 macrophages. | 1995 | Cell. Immunol. | pmid:7545550 |
| Gong N et al. | Immunoregulatory effects of sirolimus vs. tacrolimus treatment in kidney allograft recipients. | 2015 | Cell. Immunol. | pmid:26205091 |
| Koprak S et al. | Down-regulation of cell surface CXCR6 expression during T cell activation is predominantly mediated by calcineurin. | 2003 | Cell. Immunol. | pmid:12914753 |
| Tsuji-Takayama K et al. | Interleukin-18 induces interferon-gamma production through NF-kappaB and NFAT activation in murine T helper type 1 cells. | 1999 | Cell. Immunol. | pmid:10486154 |
| Kaiser E et al. | FK506-binding protein 51 interacts with Clostridium botulinum C2 toxin and FK506 inhibits membrane translocation of the toxin in mammalian cells. | 2012 | Cell. Microbiol. | pmid:22420783 |
| Stasik I et al. | The mitochondrial localization of RelB and NFATx in immature T cells. | 2008 | Cell. Mol. Biol. Lett. | pmid:18463795 |
| Fernandes JB et al. | Comparative investigation of the effects of the immunosuppressants cyclosporine A, cyclosporine G, and FK-506 on platelet activation. | 1993 | Cell. Mol. Biol. Res. | pmid:7507391 |
| Zhang X et al. | SAHA, an HDAC inhibitor, synergizes with tacrolimus to prevent murine cardiac allograft rejection. | 2012 | Cell. Mol. Immunol. | pmid:22922441 |
| Göthel SF and Marahiel MA | Peptidyl-prolyl cis-trans isomerases, a superfamily of ubiquitous folding catalysts. | 1999 | Cell. Mol. Life Sci. | pmid:10228556 |
| Sanchez-Perez I et al. | FK506 sensitizes mammalian cells to high osmolarity by modulating p38 MAP kinase activation. | 2004 | Cell. Mol. Life Sci. | pmid:15052412 |
| Yamauchi A et al. | Tacrolimus-induced neurotoxicity and nephrotoxicity is ameliorated by administration in the dark phase in rats. | 2004 | Cell. Mol. Neurobiol. | pmid:15485139 |
| Liu G et al. | FK506 Attenuates the Inflammation in Rat Spinal Cord Injury by Inhibiting the Activation of NF-κB in Microglia Cells. | 2017 | Cell. Mol. Neurobiol. | pmid:27572744 |
| Saxena K et al. | FK506 protects neurons following peripheral nerve injury via immunosuppression. | 2007 | Cell. Mol. Neurobiol. | pmid:18080746 |
| Saganová K et al. | Effects of long-term FK506 administration on functional and histopathological outcome after spinal cord injury in adult rat. | 2009 | Cell. Mol. Neurobiol. | pmid:19350383 |
| Tang J et al. | ER Stress via CHOP Pathway is Involved in FK506-Induced Apoptosis in Rat Fibroblasts. | 2016 | Cell. Physiol. Biochem. | pmid:27771715 |
| Schenk LK et al. | Cyclosporin-A induced toxicity in rat renal collecting duct cells: interference with enhanced hypertonicity induced apoptosis. | 2010 | Cell. Physiol. Biochem. | pmid:21220920 |
| Niederer KE et al. | Cypermethrin blocks a mitochondria-dependent apoptotic signal initiated by deficient N-linked glycosylation within the endoplasmic reticulum. | 2005 | Cell. Signal. | pmid:15494209 |
| Ranta F et al. | Regulation of calcineurin activity in insulin-secreting cells: stimulation by Hsp90 during glucocorticoid-induced apoptosis. | 2008 | Cell. Signal. | pmid:18611438 |
| Matta C et al. | Ser/Thr-phosphoprotein phosphatases in chondrogenesis: neglected components of a two-player game. | 2014 | Cell. Signal. | pmid:25007994 |
| Eguchi R et al. | FK506 induces endothelial dysfunction through attenuation of Akt and ERK1/2 independently of calcineurin inhibition and the caspase pathway. | 2013 | Cell. Signal. | pmid:23707520 |
| Rajapurohitam V et al. | Leptin-induced cardiomyocyte hypertrophy reveals both calcium-dependent and calcium-independent/RhoA-dependent calcineurin activation and NFAT nuclear translocation. | 2012 | Cell. Signal. | pmid:22917533 |
| Cho CS et al. | Modulation of the electrophoretic mobility of the linker for activation of T cells (LAT) by the calcineurin inhibitors CsA and FK506: LAT is a potential substrate for PKC and calcineurin signaling pathways. | 2003 | Cell. Signal. | pmid:12401523 |
| Walzel H et al. | Galectin-induced activation of the transcription factors NFAT and AP-1 in human Jurkat T-lymphocytes. | 2002 | Cell. Signal. | pmid:12135707 |
| Caneguim BH et al. | Immunosuppressant prograf® (tacrolimus) induces histopathological disorders in the peritubular tissue of rat testes. | 2011 | Cells Tissues Organs (Print) | pmid:21293102 |
| Duricová J and Grundmann M | [Cytochrome P450 3A polymorphism and its importance in cyclosporine and tacrolimus therapy in transplanted patients]. | 2007 | Ceska Slov Farm | pmid:18064802 |
| Wong WR et al. | Efficacy and safety of topically applied tacrolimus ointment in patients with moderate to severe atopic dermatitis. | 2003 | Chang Gung Med J | pmid:14515971 |
| Todd MH | Computer-aided organic synthesis. | 2005 | Chem Soc Rev | pmid:15726161 |
| Sche PP et al. | Display cloning: functional identification of natural product receptors using cDNA-phage display. | 1999 | Chem. Biol. | pmid:10508685 |
| Kley N | Chemical dimerizers and three-hybrid systems: scanning the proteome for targets of organic small molecules. | 2004 | Chem. Biol. | pmid:15157871 |
| Pruschy MN et al. | Mechanistic studies of a signaling pathway activated by the organic dimerizer FK1012. | 1994 | Chem. Biol. | pmid:9383386 |
| Chakraborty TK et al. | Design and synthesis of a rapamycin-based high affinity binding FKBP12 ligand. | 1995 | Chem. Biol. | pmid:9383417 |
| McPherson M et al. | Drug receptor identification from multiple tissues using cellular-derived mRNA display libraries. | 2002 | Chem. Biol. | pmid:12079780 |
| Tokunaga M et al. | Hereditary spastic paraplegia protein spartin is an FK506-binding protein identified by mRNA display. | 2013 | Chem. Biol. | pmid:23890011 |
| Stockwell BR and Schreiber SL | TGF-beta-signaling with small molecule FKBP12 antagonists that bind myristoylated FKBP12-TGF-beta type I receptor fusion proteins. | 1998 | Chem. Biol. | pmid:9662508 |
| Sche PP et al. | Corrigendum to: "Display cloning: functional identification of natural product receptors using cDNA-phage display" [Chemistry & Biology 6 (1999) 707-716]. | 2001 | Chem. Biol. | pmid:11325595 |
| Wells WA | Coming full circle. Vertex Pharmaceuticals, Inc. | 1998 | Chem. Biol. | pmid:9818152 |
| Butcher RA and Schreiber SL | A small molecule suppressor of FK506 that targets the mitochondria and modulates ionic balance in Saccharomyces cerevisiae. | 2003 | Chem. Biol. | pmid:12837385 |
| Clemons PA et al. | Synthesis of calcineurin-resistant derivatives of FK506 and selection of compensatory receptors. | 2002 | Chem. Biol. | pmid:11841938 |
| Mayer TU and Marx A | Five molecules we would take to a remote island. | 2010 | Chem. Biol. | pmid:20609405 |
| Michnick SW | Chemical biology beyond binary codes. | 2000 | Chem. Biol. | pmid:11137822 |
| Finney NS | Enantioselective epoxide hydrolysis: catalysis involving microbes, mammals and metals. | 1998 | Chem. Biol. | pmid:9571210 |
| Rahman S et al. | Nordihydroguiaretic acid attenuates skin tumorigenesis in Swiss albino mice with the condition of topical co-administration of an immunosuppressant. | 2015 | Chem. Biol. Interact. | pmid:25770929 |
| Kon OM | Novel immunosuppressants in asthma. | 2000 | Chem. Immunol. | pmid:12847724 |
| Bierer BE | Cyclosporin A, FK506, and rapamycin: binding to immunophilins and biological action. | 1994 | Chem. Immunol. | pmid:7524531 |
| Pathak S et al. | Preparation of High-Payload, Prolonged-Release Biodegradable Poly(lactic-co-glycolic acid)-Based Tacrolimus Microspheres Using the Single-Jet Electrospray Method. | 2016 | Chem. Pharm. Bull. | pmid:26833445 |
| Liang TT et al. | Modeling Analysis of Potential Target of Dolastatin 16 by Computational Virtual Screening. | 2018 | Chem. Pharm. Bull. | pmid:29863061 |
| Shenton JM et al. | Evidence of an immune-mediated mechanism for an idiosyncratic nevirapine-induced reaction in the female Brown Norway rat. | 2005 | Chem. Res. Toxicol. | pmid:16359170 |
| Pessah IN et al. | Structure-activity relationship for noncoplanar polychlorinated biphenyl congeners toward the ryanodine receptor-Ca2+ channel complex type 1 (RyR1). | 2006 | Chem. Res. Toxicol. | pmid:16411661 |
| Hur J et al. | Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis. | 2015 | Chem. Res. Toxicol. | pmid:25811541 |
| Masson MJ and Uetrecht JP | Tolerance induced by low dose D-penicillamine in the brown Norway rat model of drug-induced autoimmunity is immune-mediated. | 2004 | Chem. Res. Toxicol. | pmid:14727922 |